Literature DB >> 15596127

Dendritic cells in Leishmania infection.

Olga Brandonisio1, Rosa Spinelli, Maria Pepe.   

Abstract

Dendritic cells (DCs) are key elements of the immune system, which function as sentinel in the periphery and alert T lymphocytes about the type of invading antigen and address their polarisation, in order to mount an efficacious immune response. Leishmania spp. are parasitic protozoa which may cause severe disease in humans and domestic animals. In this work, the main studies concerning the role of DCs in Leishmania infection are reviewed, in both the murine and human models. In particular, the importance of the genetic status of the hosts and of the different Leishmania species in modulating DC-mediated immune response is examined. In addition, different approaches of DC-based vaccination against experimental leishmaniasis, which could have important future applications, are summarised.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15596127     DOI: 10.1016/j.micinf.2004.10.004

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  23 in total

1.  Rare association of Visceral leishmaniasis with Hodgkin's disease: A case report.

Authors:  Rakshit Kumar; Mradul K Daga; Nitish L Kamble; Arpit Sothwal; Tejinder Singh; Hemanta K Nayak; Nishant Raizada
Journal:  Infect Agent Cancer       Date:  2011-10-20       Impact factor: 2.965

2.  Nucleosides present on phlebotomine saliva induce immunossuppression and promote the infection establishment.

Authors:  Vanessa Carregaro; José M Ribeiro; Jesus G Valenzuela; Djalma L Souza-Júnior; Diego L Costa; Carlo J F Oliveira; Laís A Sacramento; Manuela S L Nascimento; Cristiane M Milanezi; Fernando Q Cunha; João S Silva
Journal:  PLoS Negl Trop Dis       Date:  2015-04-07

3.  Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.

Authors:  Marie Breton; Michel J Tremblay; Marc Ouellette; Barbara Papadopoulou
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions.

Authors:  Klaus Griewank; Caroline Gazeau; Andreas Eichhorn; Esther von Stebut
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

5.  A targeted and adjuvanted nanocarrier lowers the effective dose of liposomal amphotericin B and enhances adaptive immunity in murine cutaneous leishmaniasis.

Authors:  Pirouz M Daftarian; Geoffrey W Stone; Leticia Kovalski; Manoj Kumar; Aram Vosoughi; Maitee Urbieta; Pat Blackwelder; Emre Dikici; Paolo Serafini; Stephanie Duffort; Richard Boodoo; Alhelí Rodríguez-Cortés; Vance Lemmon; Sapna Deo; Jordi Alberola; Victor L Perez; Sylvia Daunert; Arba L Ager
Journal:  J Infect Dis       Date:  2013-07-29       Impact factor: 5.226

6.  Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection.

Authors:  René E Vasquez; Lijun Xin; Lynn Soong
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

Review 7.  Modulation of dendritic cell function by Leishmania parasites.

Authors:  Lynn Soong
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

8.  Role of natural killer cells in modulating dendritic cell responses to Leishmania amazonensis infection.

Authors:  Mayra X Hernandez Sanabria; Diego A Vargas-Inchaustegui; Lijun Xin; Lynn Soong
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

9.  Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses.

Authors:  Diego A Vargas-Inchaustegui; Lijun Xin; Lynn Soong
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 10.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.